Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azilsartan medoxomil in Korean adults with essential hypertension
NCT02203916Phase 3Completed
- Sponsor
- Takeda
- Start
- Jul 2014
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of azilsartan medoxomil in essential hypertension, sponsored by Takeda. Started Jul 2014; status: completed.
02
Drugs
azilsartan medoxomil
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT02203916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02203916.